Cambridge Investment Research Advisors
TBIO

Cambridge Investment Research Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,800
Closed -$242K – 3257
2021
Q2 		$242K Buy
+8,800
New +$173K ﹤0.01% 2654

Cambridge Investment Research Advisors's TBIO Position: Q3 2021 in Review

Cambridge Investment Research Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 8,800 shares — an estimated $242K sold.

Cambridge Investment Research Advisors first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $242K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Cambridge Investment Research Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 8,800 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $242K.
  • Cambridge Investment Research Advisors first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Translate Bio, Inc. Common Stock position peaked at $242K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.